30 August 2018: Sysmex, Toppan Printing, and RIKEN GENESIS Commence Launch of Fully Automated System (Research Use Only) to Detect Gene Mutations in Cancer Tissue

Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu), Toppan Printing Co., Ltd. (HQ: Tokyo, Japan; President & Representative Director: Shingo Kaneko) and RIKEN GENESIS Co., Ltd. (HQ: Tokyo, Japan; President & CEO; Naoto Kondo) have jointly developed the LW-100 Gene Measurement Analyzer (research use only) and a group of related reagents as a system to fully automate testing to detect gene mutations in cancer tissue.

23 August 2018: Sysmex Partec’s CyFlow™ Counter System, a System to Test for CD4+ Lymphocytes, Receives WHO Prequalification

Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) provides notice that the CyFlow™ Counter System (CyFlow™ Counter with CD4 easy count kit and CD4% easy count kit), developed and produced by its subsidiary Sysmex Partec (“Partec”), has received WHO prequalification. This testing system helps diagnose and monitor the immune status of people infected with HIV by checking CD4 in human blood samples. This marks the first time a Sysmex Group product has received WHO prequalification.